PR
Immutep Ltd
PRRUF · OTC
$0.04 -5.25% (-$0.00)
Market Cap $82.8M
P/E Ratio -
Div. Yield -
ROE 66.49%
Piotroski F-Score Moderate
4/9Valuation
64 /100
Fair P/S 5.70x
P/B 1.35x
P/E N/A
Growth
78 /100
Growing Rev. growth 60.66%
Book val. growth 23.35%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 83.01%
Net margin 544.79%
Op. margin 576.21%
Quality
2 /100
Poor ROIC 120.87%
ROE 66.49%
ROA 95.24%
Debt
69 /100
Low Debt/Equity 0.02x
Current ratio 5.69x
Int. coverage -1,235.43x
Stability
23 /100
Unstable Beta 2.20x
Rev. volatility 97.47%
EPS volatility 25.03%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na PRRUF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Marc Voigt
Employees
1,027
Headquarters
Sydney
Nadcházející události
25 ÚNO
Earnings
Upcoming earnings report